Post-surgical pain: evolving drug treatments and challenges.

Area of Science:

• Anesthesiology and Pain Management
• Pharmacology
• Clinical Practice

Background:

• Effective postoperative pain control is crucial for patient recovery and preventing chronic pain.
• Multimodal analgesia is adopted but inconsistently implemented.
• Systemic, clinical, and institutional barriers hinder optimal pain management.

Purpose of the Study:

• To review current and emerging pharmacologic agents for postoperative pain.
• To critically appraise novel formulations and adjunct therapies.
• To identify barriers to clinical implementation of advanced pain management strategies.

Main Methods:

• Systematic review of pharmacologic agents for postoperative pain.
• Evaluation of established drugs (acetaminophen, NSAIDs, ketamine).
• Appraisal of novel formulations and adjunct agents (e.g., vitamin C, duloxetine).

Main Results:

• An expanding pharmacologic arsenal exists, including novel agents showing promise in reducing opioid use.
• Newer agents demonstrate potential for improved recovery.
• Clinical implementation is limited by cost, provider familiarity, and insufficient real-world evidence.

Conclusions:

• Despite promising new agents, widespread adoption for postoperative pain is hindered by cost and data limitations.
• Bridging the gap between innovation and practice requires coordinated research, education, and policy efforts.
• Addressing implementation barriers is key to advancing postoperative pain management.